Skip to content Go to main menu
COMPANY

Company

About us

SECTOR

  • Bio-Healthcare_.jpg

    Bio-Healthcare

  • Financials-Fintech_.jpg

    Financials-Fintech

  • about-icn1.png

    35

    Funds under management
    (Cumulative)

  • about-icn2.png

    4,123

    Million

    Assets under management
    (Cumulative, KRW)

  • about-icn3.png

    103

    Number of current portfolio companies

History

2024

03

Selected as GP of Korea Growth Investment Corp Fund (Fintech)

01

Sean Shin appointed as Co-CEO

2023

06

Selected as operator for Scale-up TIPS

06

Achieved 400 billion KRW in cumulative Assets Under Management (AUM)

2022

03

Selected as GP of Korea Venture Investment Corp (Vaccine·Bio)

2021

09

Achieved 300 billion KRW in cumulative Assets Under Management (AUM)

2020

11

Achieved 200 billion KRW in cumulative Assets Under Management (AUM)

2019

09

Selected as operator for TIPS

04

Selected as GP of Korea Venture Investment Corp (Early Stage)

01

Achieved 100 billion KRW in cumulative Assets Under Management (AUM)

01

Acquisition of accelerator license

2018

08

Acquisition of PEF license

05

Seung-Ho Lee appointed as CEO

2014

10

Acquisition of venture capital license

09

Incorporation of DAYLI Partners